WWTFBudget

The $25 PBS cap is a myth — here's what actually changed

PBS co-payment stays around $31.60. The real change: bulk-billing GP incentives tripled.

WTFBudget Editorial
Share
Pharmacy interior with prescription medicines
Pharmacy interior with prescription medicines
11 min read
Font size

PBS & Bulk Billing — demystified

Does this affect me?

If you see a GP and you've got a Commonwealth concession card or a kid under 16 — yes, in your favour. Your GP gets paid a bigger incentive to bulk-bill you, so more practices should keep your visits free. If you're a working-age adult with no concession card, the change is indirect — your GP might be more financially comfortable bulk-billing, but it's still their call. PBS medicine prices aren't dropping further in this Budget.

Quick test:

  • Have a Commonwealth concession card (pensioner, Health Care Card, DVA)? Bigger incentive paid to your GP to bulk-bill you.
  • Have a child under 16? Same — tripled incentive applies.
  • Working-age adult, no concession card? No direct change — bulk billing remains your GP's choice (now slightly easier for them economically).
  • Got a baby due? RSV vaccine becomes free on PBS for eligible infants — saves up to ~$400.
  • Need urgent non-emergency care (UTI, minor fracture, asthma)? 137 bulk-billed Urgent Care Clinics rolling out by July 2026 — find your nearest at health.gov.au/medicare-ucc.
  • PBS medicine co-payment? Still $31.60 general / $7.70 concession — the "$25 cap" doing the rounds online is not in this Budget.

TL;DR

The Budget delivers $11.4 billion for bulk-billing incentives (target: 9-in-10 GP visits bulk-billed by 2030) and $5.9 billion for new PBS medicine listings (including $449.3M for the RSV vaccine). It does not introduce a $25 PBS co-payment cap — that figure circulating publicly is a misreading of separate prior reforms.

"Tripling bulk billing" means tripling the incentive payment to GPs for bulk-billing eligible patients, not "three times as many bulk-billed visits." It's a payment-rate change designed to shift GP economics, not a quota.

Jargon decoder:

  • Bulk billing = your GP charges Medicare directly and you pay $0 out of pocket. The alternative is the GP charging a private fee, you pay it, then claim a Medicare rebate back (leaving a "gap").
  • Medicare rebate = the dollar amount Medicare pays for a standard consult (~$42.85 for a Level B / Item 23). Unchanged in this Budget.
  • Bulk-billing incentive = an extra payment to the GP on top of the rebate, paid when they bulk-bill an eligible patient. This is the bit being tripled.
  • PBS (Pharmaceutical Benefits Scheme) = the federal scheme that subsidises medicine prices. The co-payment is the amount you pay at the pharmacy.
  • Concession card holder = pensioner, Health Care Card holder, DVA card holder, or similar. Triggers the tripled incentive.
  • PBAC = Pharmaceutical Benefits Advisory Committee — the body that decides which medicines get PBS-listed.

What's NOT in this budget

  • A $25 PBS co-payment cap. The PBS general co-payment maximum and pension co-payment maximum are set separately and weren't reduced to $25 in this Budget. Earlier Albanese-government reforms (2022 and 2024) reduced the general co-payment from $42.50 to $31.60 and froze it. Some commentary conflates that history with this Budget.
  • A new universal Medicare card payment per visit — Medicare rebates work the same way.
  • Means-tested bulk billing — bulk billing remains a GP choice (incentivised), not means-tested.

What IS in this budget

Bulk-billing incentives — $11.4B

  • Tripled bulk-billing incentive payment to GPs for bulk-billing eligible patients (Commonwealth Concession Card holders, children under 16). The tripling refers to the incentive amount paid to the GP, not the number of bulk-billed visits.
  • Goal: 9-in-10 GP visits bulk-billed by 2030.
  • Designed to shift GP economics so bulk billing is more financially viable.

New PBS listings — $5.9B

  • Funding to list new and amended PBS medicines over the forward estimates.
  • Includes $449.3M for the RSV vaccine to be PBS-listed (free for eligible infants and other groups).

Medicare Urgent Care Clinics — $1.8B + $580.2M/yr ongoing

  • 137 clinics nationwide.
  • 4-in-5 Australians within 20-minute drive by July 2026.
  • Bulk-billed urgent care — alternative to ED for non-emergency cases.
  • Cost-of-living relief: avoid $300+ ED visits or after-hours GP fees.

Regional bulk-billing pilots — $25.3M

  • 6 fully bulk-billing GP clinics across Central Coast, Newcastle, Lake Macquarie, Hunter regions.

Key dates

EventDate
Tripled bulk-billing incentive starts1 November 2025 (announced earlier, continuing into this Budget)
Bulk-billing target9-in-10 by 2030
137 Urgent Care Clinics rolloutBy July 2026
New PBS listingsOngoing — phased over forward estimates

What "tripling bulk billing" actually means

Pre-reform: GP gets a small incentive payment on top of the Medicare rebate when they bulk-bill an eligible patient (concession card holder, child under 16).

Post-reform: That incentive payment is tripled — so GPs are paid more to bulk-bill eligible patients.

The "tripling" is the payment rate, not the share of visits bulk-billed. The share of bulk-billed visits should rise because of the tripled incentive, but the policy mechanism is a payment increase, not a quota.

For a standard Level B consult (Item 23) for an eligible patient in a metropolitan area:

  • Medicare rebate: $42.85
  • Old incentive: ~$6.85
  • New tripled incentive: ~$20.55
  • Total to GP: ~$63.40 (vs old ~$49.70)

This brings the all-in payment closer to the typical private fee, reducing the GP's economic loss from bulk-billing.

Worked example — June, 71, pensioner

  • June visits GP twice a month for ongoing care.
  • All visits are bulk-billed (she's a concession card holder).
  • Out-of-pocket cost for June: $0 (unchanged — bulk billing was already standard for pensioners).
  • Effect on June: none directly, but her GP is now $14/visit better off, making the practice more financially stable.

Worked example — Mark, chef on $75k, no concession card

  • Mark is NOT eligible for the tripled bulk-billing incentive (it's targeted to concession card holders and children under 16).
  • His GP may bulk-bill him voluntarily or charge a gap fee — that's the doctor's choice.
  • The 9-in-10 target depends on practices moving general (non-concession) adult patients into bulk billing too — which is harder economically.
  • For Mark: depends on his GP's practice policy. Most working-age adults still face some gap fees.

Worked example — RSV vaccine

  • The RSV vaccine becomes PBS-listed (from this $449.3M allocation).
  • Eligible infants: free.
  • Cost without PBS listing: $200-$400.
  • Direct saving to families with eligible babies: up to ~$400 per child.

Worked example — Urgent Care Clinic visit

  • Sam (chef, no concession) wakes up with a UTI on a Sunday.
  • Alternatives: ED ($300+ effective wait), urgent after-hours GP ($150+ private fee).
  • Urgent Care Clinic visit: bulk-billed, $0 out of pocket.

Myths vs reality

Myth 1: "Tripling bulk billing means 3x as many visits" — FALSE

It means the incentive payment to the GP is tripled. The expected outcome is more bulk-billed visits, but the mechanism is a payment rate.

Myth 2: "PBS co-payment is now $25" — FALSE FOR THIS BUDGET

This Budget does not introduce a $25 PBS cap. The PBS general co-payment maximum is set by separate legislation and remains around $31.60 (frozen from prior reforms). Concessional co-payment is around $7.70. The $25 figure circulating is either misremembered or from prior election commitments, not the 2026-27 Budget.

Myth 3: "Every GP visit is now free" — FALSE

Bulk billing is the GP's choice. The tripled incentive makes bulk billing more economic for concession card holders and kids under 16. Working-age adults with no concession card may still face gap fees depending on the practice. The 9-in-10 target by 2030 is aspirational, not guaranteed.

Myth 4: "RSV vaccine is free for everyone" — DEPENDS

RSV vaccine is PBS-listed for eligible groups (eligible infants and certain at-risk adults). Not universally free for all adults — eligibility criteria apply.

Myth 5: "Urgent Care Clinics replace EDs" — FALSE

UCCs handle non-emergency cases (UTIs, minor fractures, asthma flares). True emergencies still go to ED.

Myth 6: "Bulk billing rates won't actually rise" — CONTESTED

This is a legitimate debate. Royal Australian College of GPs (RACGP) supports the incentive uplift but warns that general adult bulk-billing depends on whether the tripling is extended to non-concession patients. Currently it's only triple for concession + kids under 16. Whether 9-in-10 is achievable without expanding the incentive to all patients is genuinely contested.

Myth 7: "Bulk-billing rates are means-tested" — PARTLY TRUE

The tripled incentive is conditional on the patient being a concession card holder or under 16. Non-concession working-age adults rely on the GP's voluntary bulk-billing choice (incentive isn't tripled for them).

Myth 8: "Medicare rebate has been increased" — FALSE

Medicare rebate levels are unchanged. The bulk-billing incentive is what's been tripled. (These are different things — the rebate is what Medicare pays for the consultation; the incentive is a separate payment for choosing to bulk-bill.)

Myth 9: "Pharmaceutical companies got a windfall" — MIXED

The $5.9B new PBS listings funding pays for listing specific medicines (each through PBAC process). Pharma manufacturers benefit through PBS uptake of their drugs. Whether this is a "windfall" depends on the listed medicines' clinical and economic value — PBAC's role is to ensure value for money.

Myth 10: "Bulk billing is unsustainable for GPs at any rate" — CONTESTED

The Budget settles bulk billing at a higher payment rate that's closer to private fees but still below them for many consultation types. Whether this is enough for general adult bulk billing to become standard practice is the central uncertainty.

But what if...

...my GP charged me a $40 gap fee last week — does that go away now? Not automatically. The tripled incentive only applies if you're a concession card holder or under 16. For working-age adults with no card, your GP still chooses whether to bulk-bill or charge a gap. They get nothing extra under this Budget for bulk-billing you, so the gap fee may stay.

...I'm a pensioner — is my GP going to bulk-bill me now? Probably more likely. Bulk billing was already standard for most pensioners, and now your GP gets ~$14 more per visit on top. Practices that were marginal on bulk billing should now find it more viable. Find a bulk-billing practice via healthdirect.gov.au.

...my baby is due in 2026 — is the RSV vaccine actually free? For eligible infants, yes — funded via the $449.3M PBS allocation. Your maternity hospital or GP will tell you if you qualify (eligibility is set in the PBS listing). Without PBS funding it would have cost $200-$400 per child.

...I'm on lots of medications — is my pharmacy bill dropping further? Not in this Budget. PBS general co-payment stays at ~$31.60, concession at ~$7.70 (both frozen from earlier reforms). The "$25 PBS cap" doing the rounds online is not in the 2026-27 papers.

...what's a Medicare Urgent Care Clinic and why would I use one? A bulk-billed walk-in clinic for non-emergency stuff that's too urgent for a regular GP appointment — UTIs, minor fractures, asthma flares, kids' fevers. Free at the point of care. 137 of them by July 2026, with 4-in-5 Australians within a 20-minute drive. Cheaper alternative to a $300+ ED visit or a $150+ after-hours GP.

...will my GP visits still be free if I move regional / rural? Bulk-billing rates are historically lower in regional and remote areas due to workforce shortages. The tripled incentive helps but doesn't fix the workforce problem on its own. There are 6 new fully bulk-billing pilot clinics in Central Coast / Newcastle / Lake Macquarie / Hunter to test the model.

Where genuine debate lives

  1. Whether the tripled incentive is enough to hit 9-in-10 by 2030 — RACGP says only with further expansion.
  2. Whether GPs will pass the higher incentive into reduced gap fees for non-concession patients — pricing behaviour uncertain.
  3. Workforce shortages — even fully-funded bulk billing fails if there aren't enough GPs.
  4. Rural and remote bulk-billing economics — practice viability is harder; targeted measures may need expansion.
  5. Urgent Care Clinics' impact on ED demand — early data suggests modest reduction but not transformative.

A useful filter

When you see a PBS or bulk-billing claim:

  1. PBS or Medicare? They're different — PBS is medicines, Medicare is consultations.
  2. Incentive vs rebate? Tripling is incentive, not rebate.
  3. Concession card holder or general patient? Treatment differs.
  4. Universal or targeted? Most measures are targeted.

Sources

Related

Share

More in Healthcare